P. Jeffrey Conn left a full professorship for a job in Big Pharma 11 years ago because he saw no path in academe to turn his novel idea for treating Parkinson's disease into an actual drug. Now he and a corps of scientists are closing in on a molecule that could bring relief to the millions suffering with the condition's debilitating tremors and paralysis.
But the screening, testing, formulating, and reformulating that brought Mr. Conn's team to this point didn't...
To read the full, original article click on this link: Big Pharma Finds a Home on Campus - Administration - The Chronicle of Higher Education
Author: Goldie Blumenstyk
